Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 21.02.17 in Vol 5, No 2 (2017): February

This paper is in the following e-collection/theme issue:

Works citing "Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia"

Earle E Bain, Laura Shafner, David P Walling, Ahmed A Othman, Christy Chuang-Stein, John Hinkle, Adam Hanina

JMIR Mhealth Uhealth 2017 (Feb 21); 5(2):e18 

According to Crossref, the following articles are citing this article (DOI 10.2196/mhealth.7030):

(note that this is only a small subset of citations)

  1. Gognieva DG, Shchekochikhin DY, Gavrilova EV, Syrkina EA, Bogdanova RS, Syrkin AL, Kopylov PY. The problem of adherence to treatment in general medical practice. Kardiologiya i serdechno-sosudistaya khirurgiya 2019;12(6):510
    CrossRef
  2. Velligan DI, Maples NJ, Pokorny JJ, Wright C. Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?. Schizophrenia Research 2020;215:17
    CrossRef
  3. . An AI boost for clinical trials. Nature 2019;573(7775):S100
    CrossRef
  4. Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ. Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine & Tobacco Research 2020;22(12):2134
    CrossRef
  5. Gandhi M, Bacchetti P, Spinelli MA, Okochi H, Baeten JM, Siriprakaisil O, Klinbuayaem V, Rodrigues WC, Wang G, Vincent M, Cressey TR, Drain PK. Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test. JAIDS Journal of Acquired Immune Deficiency Syndromes 2019;81(1):72
    CrossRef
  6. Fogel AL, Kvedar JC. Artificial intelligence powers digital medicine. npj Digital Medicine 2018;1(1)
    CrossRef
  7. McCaul ME, Wand GS. Detecting Deception in Our Research Participants: Are Your Participants Who You Think They Are?. Alcoholism: Clinical and Experimental Research 2018;42(2):230
    CrossRef
  8. Krittanawong C, Bomback AS, Baber U, Bangalore S, Messerli FH, Wilson Tang WH. Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension. Current Hypertension Reports 2018;20(9)
    CrossRef
  9. Fiske A, Henningsen P, Buyx A. Your Robot Therapist Will See You Now: Ethical Implications of Embodied Artificial Intelligence in Psychiatry, Psychology, and Psychotherapy. Journal of Medical Internet Research 2019;21(5):e13216
    CrossRef
  10. Barrett M, Boyne J, Brandts J, Brunner-La Rocca H, De Maesschalck L, De Wit K, Dixon L, Eurlings C, Fitzsimons D, Golubnitschaja O, Hageman A, Heemskerk F, Hintzen A, Helms TM, Hill L, Hoedemakers T, Marx N, McDonald K, Mertens M, Müller-Wieland D, Palant A, Piesk J, Pomazanskyi A, Ramaekers J, Ruff P, Schütt K, Shekhawat Y, Ski CF, Thompson DR, Tsirkin A, van der Mierden K, Watson C, Zippel-Schultz B. Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care. EPMA Journal 2019;10(4):445
    CrossRef
  11. Herrmann M, Boehme P, Hansen A, Jansson K, Rebacz P, Ehlers JP, Mondritzki T, Truebel H. Digital Competencies and Attitudes Toward Digital Adherence Solutions Among Elderly Patients Treated With Novel Anticoagulants: Qualitative Study. Journal of Medical Internet Research 2020;22(1):e13077
    CrossRef
  12. Van Biesen W, Decruyenaere J, Sideri K, Cockbain J, Sterckx S. Remote digital monitoring of medication intake: methodological, medical, ethical and legal reflections. Acta Clinica Belgica 2021;76(3):209
    CrossRef
  13. Mak K, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today 2019;24(3):773
    CrossRef
  14. Boehme P, Wienand P, Herrmann M, Truebel H, Mondritzki T. New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next century. Medical Hypotheses 2017;108:46
    CrossRef
  15. Steinkamp JM, Goldblatt N, Borodovsky JT, LaVertu A, Kronish IM, Marsch LA, Schuman-Olivier Z. Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review. JMIR Mental Health 2019;6(3):e12493
    CrossRef
  16. Eggerth A, Hayn D, Schreier G. Medication management needs information and communications technology‐based approaches, including telehealth and artificial intelligence. British Journal of Clinical Pharmacology 2020;86(10):2000
    CrossRef
  17. Graham S, Depp C, Lee EE, Nebeker C, Tu X, Kim H, Jeste DV. Artificial Intelligence for Mental Health and Mental Illnesses: an Overview. Current Psychiatry Reports 2019;21(11)
    CrossRef
  18. Koesmahargyo V, Abbas A, Zhang L, Guan L, Feng S, Yadav V, Galatzer-Levy IR. Accuracy of machine learning-based prediction of medication adherence in clinical research. Psychiatry Research 2020;294:113558
    CrossRef
  19. Vatansever S, Schlessinger A, Wacker D, Kaniskan H, Jin J, Zhou M, Zhang B. Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions. Medicinal Research Reviews 2021;41(3):1427
    CrossRef
  20. Väänänen A, Haataja K, Vehviläinen-Julkunen K, Toivanen P. AI in healthcare: A narrative review. F1000Research 2021;10:6
    CrossRef
  21. Aggarwal N, Ahmed M, Basu S, Curtin JJ, Evans BJ, Matheny ME, Nundy S, Sendak MP, Shachar C, Shah RU, Thadaney-Israni S. Advancing Artificial Intelligence in Health Settings Outside the Hospital and Clinic. NAM Perspectives 2020;
    CrossRef
  22. Dockendorf MF, Hansen BJ, Bateman KP, Moyer M, Shah JK, Shipley LA. Digitally Enabled, Patient‐Centric Clinical Trials: Shifting the Drug Development Paradigm. Clinical and Translational Science 2021;14(2):445
    CrossRef
  23. Liu AY, Laborde ND, Coleman K, Vittinghoff E, Gonzalez R, Wilde G, Thorne AL, Ikeguchi E, Shafner L, Sunshine L, van der Straten A, Siegler AJ, Buchbinder S. DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men. AIDS and Behavior 2021;25(4):1001
    CrossRef
  24. . Design and conduct of confirmatory chronic pain clinical trials. PAIN Reports 2021;6(1):e845
    CrossRef
  25. Devine EG, Pingitore AM, Margiotta KN, Hadaway NA, Reid K, Peebles K, Hyun JW. Frequency of concealment, fabrication and falsification of study data by deceptive subjects. Contemporary Clinical Trials Communications 2021;21:100713
    CrossRef
  26. Curto M, Fazio F, Ulivieri M, Navari S, Lionetto L, Baldessarini RJ. Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment. Expert Opinion on Pharmacotherapy 2021;22(9):1143
    CrossRef
  27. Chivilgina O, Elger BS, Jotterand F. Digital Technologies for Schizophrenia Management: A Descriptive Review. Science and Engineering Ethics 2021;27(2)
    CrossRef
  28. Larsen KG, Areberg J, Åström DO. Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteers. Clinical Trials 2021;18(4):505
    CrossRef
  29. Christie RH, Abbas A, Koesmahargyo V, Mirelman A, Dorsey ER, Brundin P, Bloem BR. Technology for Measuring and Monitoring Treatment Compliance Remotely. Journal of Parkinson's Disease 2021;11(s1):S77
    CrossRef
  30. Babel A, Taneja R, Mondello Malvestiti F, Monaco A, Donde S. Artificial Intelligence Solutions to Increase Medication Adherence in Patients With Non-communicable Diseases. Frontiers in Digital Health 2021;3
    CrossRef
  31. Schuhmacher A, Brieke C, Gassmann O, Hinder M, Hartl D. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D. Drug Discovery Today 2021;26(12):2786
    CrossRef
  32. Salcedo J, Rosales M, Kim JS, Nuno D, Suen S, Chang AH, Durand-Zaleski I. Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study. PLOS ONE 2021;16(7):e0254950
    CrossRef
  33. Weissler EH, Naumann T, Andersson T, Ranganath R, Elemento O, Luo Y, Freitag DF, Benoit J, Hughes MC, Khan F, Slater P, Shameer K, Roe M, Hutchison E, Kollins SH, Broedl U, Meng Z, Wong JL, Curtis L, Huang E, Ghassemi M. The role of machine learning in clinical research: transforming the future of evidence generation. Trials 2021;22(1)
    CrossRef
  34. Bijral RK, Singh I, Manhas J, Sharma V. Exploring Artificial Intelligence in Drug Discovery: A Comprehensive Review. Archives of Computational Methods in Engineering 2022;29(4):2513
    CrossRef
  35. Siripurapu S, Darimireddy NK, Chehri A, Sridhar B, Paramkusam AV. Technological Advancements and Elucidation Gadgets for Healthcare Applications: An Exhaustive Methodological Review-Part-I (AI, Big Data, Block Chain, Open-Source Technologies, and Cloud Computing). Electronics 2023;12(3):750
    CrossRef
  36. Walton KM, Herrmann ES. Medication adherence in tobacco cessation clinical trials. Addiction Neuroscience 2023;6:100069
    CrossRef
  37. Väänänen A, Haataja K, Vehviläinen-Julkunen K, Toivanen P. AI in healthcare: A narrative review. F1000Research 2021;10:6
    CrossRef
  38. Kwon S, Firth J, Joshi D, Torous J. Accessibility and availability of smartphone apps for schizophrenia. Schizophrenia 2022;8(1)
    CrossRef
  39. Correll CU, Solmi M, Cortese S, Fava M, Højlund M, Kraemer HC, McIntyre RS, Pine DS, Schneider LS, Kane JM. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents. World Psychiatry 2023;22(1):48
    CrossRef
  40. Ray A, Bhardwaj A, Malik YK, Singh S, Gupta R. Artificial intelligence and Psychiatry: An overview. Asian Journal of Psychiatry 2022;70:103021
    CrossRef
  41. Khan NZ, Javed MA. Use of Artificial Intelligence-Based Strategies for Assessing Suicidal Behavior and Mental Illness: A Literature Review. Cureus 2022;
    CrossRef
  42. Mason M, Cho Y, Rayo J, Gong Y, Harris M, Jiang Y. Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review. JMIR mHealth and uHealth 2022;10(3):e35157
    CrossRef
  43. Schmidt A, Balitzki J, Grmaca L, Vogel J, Boehme P, Boden K, Hüser J, Truebel H, Mondritzki T. “Digital biomarkers” in preclinical heart failure models — a further step towards improved translational research. Heart Failure Reviews 2022;28(1):249
    CrossRef
  44. Krittanawong C, Johnson KW, Tang WW. How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology. Personalized Medicine 2019;16(2):87
    CrossRef
  45. Adje YH, Brooks KM, Castillo-Mancilla JR, Wyles DL, Anderson PL, Kiser JJ. The use of technology-based adherence monitoring in the treatment of hepatitis C virus. Therapeutic Advances in Infectious Disease 2022;9:204993612210956
    CrossRef
  46. Goodman GR, Vaz C, Albrechta H, Boyer EW, Mayer KH, O’Cleirigh C, Chai PR. Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy. Current HIV/AIDS Reports 2022;19(5):433
    CrossRef
  47. Bohlmann A, Mostafa J, Kumar M. Machine Learning and Medication Adherence: Scoping Review. JMIRx Med 2021;2(4):e26993
    CrossRef
  48. Correia FD, Molinos M, Luís S, Carvalho D, Carvalho C, Costa P, Seabra R, Francisco G, Bento V, Lains J. Digitally Assisted Versus Conventional Home-Based Rehabilitation After Arthroscopic Rotator Cuff Repair. American Journal of Physical Medicine & Rehabilitation 2022;101(3):237
    CrossRef
  49. Buchbinder SP, Siegler AJ, Coleman K, Vittinghoff E, Wilde G, Lockard A, Scott H, Anderson PL, Laborde N, van der Straten A, Christie RH, Marlborough M, Liu AY. Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men. AIDS and Behavior 2023;27(2):719
    CrossRef
  50. Tiribelli S, Monnot A, Shah SF, Arora A, Toong PJ, Kong S. Ethics Principles for Artificial Intelligence–Based Telemedicine for Public Health. American Journal of Public Health 2023;113(5):577
    CrossRef
  51. . Current Status and Future Direction of Artificial Intelligence in Healthcare and Medical Education. Korean Medical Education Review 2020;22(2):99
    CrossRef
  52. Lu M, Yin J, Zhu Q, Lin G, Mou M, Liu F, Pan Z, You N, Lian X, Li F, Zhang H, Zheng L, Zhang W, Zhang H, Shen Z, Gu Z, Li H, Zhu F. Artificial Intelligence in Pharmaceutical Sciences. Engineering 2023;27:37
    CrossRef
  53. McIntyre RS, Greenleaf W, Bulaj G, Taylor ST, Mitsi G, Saliu D, Czysz A, Silvesti G, Garcia M, Jain R. Digital health technologies and major depressive disorder. CNS Spectrums 2023;28(6):662
    CrossRef
  54. Chakraborty C, Bhattacharya M, Dhama K, Agoramoorthy G. Artificial intelligence–enabled clinical trials might be a faster way to perform rapid clinical trials and counter future pandemics: lessons learned from the COVID-19 period. International Journal of Surgery 2023;109(5):1535
    CrossRef
  55. Malik MA, Faraone SV, Michoel T, Haavik J. Use of big data and machine learning algorithms to extract possible treatment targets in neurodevelopmental disorders. Pharmacology & Therapeutics 2023;250:108530
    CrossRef
  56. . Use of Artificial Intelligence in Drug Discovery and its Application in Drug Development. Asian Journal of Research in Chemistry 2023;:83
    CrossRef
  57. Ekpezu AO, Wiafe I, Oinas-Kukkonen H. Predicting Adherence to Behavior Change Support Systems using Machine Learning: A Systematic Review (Preprint). JMIR AI 2023;
    CrossRef
  58. Peng W, Bai X, Yang Y, Cui J, Xu W, Song L, Yang H, He W, Zhang Y, Zhang X, Li X, Lu J. Healthy lifestyle, statin, and mortality in people with high CVD risk: A nationwide population-based cohort study. American Journal of Preventive Cardiology 2024;17:100635
    CrossRef
  59. Romagnoli A, Ferrara F, Langella R, Zovi A. Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical Research 2024;41(4):721
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/mhealth.7030):

  1. Lu P, Yang Y, Liu S, Xie L, Lure F, Li M. Tuberculosis Control in Migrating Population. 2020. Chapter 9:191
    CrossRef
  2. De Geest SM, Ribaut J, Denhaerynck K, Dobbels F. Psychosocial Aspects of Chronic Kidney Disease. 2021. :409
    CrossRef
  3. Santoshi S, Sengupta D. Artificial Intelligence and Machine Learning in Healthcare. 2021. Chapter 4:71
    CrossRef
  4. . Artificial Intelligence in Medicine. 2021. Chapter 214-1:1
    CrossRef
  5. . Artificial Intelligence in Medicine. 2022. Chapter 214:1595
    CrossRef
  6. Chavda VP, Vihol D, Patel A, Redwan EM, Uversky VN. Bioinformatics Tools for Pharmaceutical Drug Product Development. 2023. :1
    CrossRef
  7. Saikia S, Prajapati JB, Prajapati BG, Padma VV, Pathak YV. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology. 2022. Chapter 5:67
    CrossRef
  8. Pokhriyal P, Chavda VP, Pathak M. Bioinformatics Tools for Pharmaceutical Drug Product Development. 2023. :401
    CrossRef
  9. Naeem A, Suhail M, Basit A, Yali L, Xia ZM, Qin Z, Ming Y. A Handbook of Artificial Intelligence in Drug Delivery. 2023. :499
    CrossRef
  10. Argenson A, Devi-Chou V. Principles of Gender-Specific Medicine. 2023. :601
    CrossRef
  11. Nag A, Das A, Sil R, Kar A, Mandal D, Das B. Intelligent Systems Design and Applications. 2023. Chapter 13:128
    CrossRef
  12. Das DR, Satpathy I, Patnaik BCM. AI and IoT-Based Technologies for Precision Medicine. 2023. chapter 7:108
    CrossRef
  13. Mancini A, Fabbo A. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders. 2023. Chapter 33:345
    CrossRef
  14. Fielding KL, Subbaraman R, Khan A, Celan C, Charalambous S, Franke MF, Huddart S, Katamba A, Law S, Stagg HR. Digital Respiratory Healthcare. 2023. 14:170
    CrossRef
  15. Mourelatou EA, Iosif E, Galatou E, Sarigiannis Y, Vlasiou MC, Zacharia L, Petrou CC. Novel Formulations and Future Trends. 2024. :415
    CrossRef